user avatar
Mike Thompson, MD, PhD, FASCO
@mtmdphd
VP Clinical Partnerships @TempusAI #PrecisionMedicine #mmsm #lymsm #MDSsm #leusm #CCC19 @COVID19nCCC @ASCO COI: coi.asco.org/share/RBB-TT6R…
Milwaukee, WI
linkedin.com/in/michaelthom…
Joined September 2010
3,990
Following
23K
Followers
Posts
  • Pinned
    user avatar
    Mike Thompson, MD, PhD, FASCO
    @mtmdphd
    Dec 5, 2025
    Myeloma / PCD ~ #ASH25Top10 (or so) #mmsm #mmMRD #ASH25 - @mtmdphd – DRAFT Update: 12/5/25v2 - @grpetersen1 – @IrenemGhobrial @Taxkourel @RahulBanerjeeMD @AuclairDan @JanakiramMurali @jmikhaelmd @End_myeloma @bdermanmd @szusmani @DrOlaLandgren @MyelomaTeacher @VincentRK @ManniMD1
    3.1K
  • user avatar
    Mike Thompson, MD, PhD, FASCO
    @mtmdphd
    Sep 11, 2020
    "Reply To All" should require two-factor authentication, pop-ups, and a waiting period...
  • user avatar
    Mike Thompson, MD, PhD, FASCO
    @mtmdphd
    May 29, 2019
    "Reply To All" should require two-factor authentication, pop-ups, and a waiting period...
  • user avatar
    Mike Thompson, MD, PhD, FASCO
    @mtmdphd
    Jun 5, 2023
    Today is my last day of serving on the @ASCO Board of Directors. It has been the highlight of my career. I enjoyed working with ASCO staff, C-suite, & other volunteers. I encourage you to volunteer & donate time & money to ASCO & @ConquerCancerFd #ASCO23 volunteer.asco.org
    8.6K
  • user avatar
    Mike Thompson, MD, PhD, FASCO
    @mtmdphd
    Dec 19, 2018
    Thank you for all of the kind words and congratulations on Twitter, email, and elsewhere today. I look forward to serving on the @ASCO Board starting at/after the #ASCO19 Annual Meeting.
  • user avatar
    Mike Thompson, MD, PhD, FASCO
    @mtmdphd
    Jan 21, 2021
    Replying to @sistercrow @megtirrell and @WhiteHouse
    It's been less than 24 hours.
  • user avatar
    Mike Thompson, MD, PhD, FASCO
    @mtmdphd
    Aug 29, 2021
    Replying to @QaaliHussein1 and @DGlaucomflecken
    Point of care @DGlaucomflecken video beats corporate wellness consulting group
  • user avatar
    Mike Thompson, MD, PhD, FASCO
    @mtmdphd
    Nov 7, 2020
    Interpreting Diagnostic Tests for SARS-CoV-2 [May 6, 2020] @NandiniSethura1 et al. @JAMA_current ow.ly/9GQU30qDLpq #CCC19 #2019nCoV #COVID19 #Testing
  • user avatar
    Mike Thompson, MD, PhD, FASCO
    @mtmdphd
    Mar 22, 2018
    The Proposal to Lower P Value Thresholds to .005 [3/22/18] John P. A. Ioannidis @JAMA_current
    The Proposal to Lower P Value Thresholds to .005
    From jamanetwork.com
  • user avatar
    Mike Thompson, MD, PhD, FASCO
    @mtmdphd
    Nov 6, 2022
    Practical Considerations for the Use of Circulating Tumor DNA [ctDNA] in the Treatment of Patients With Cancer: A Narrative Review [Oct 20, 2022] @MatthewGKrebs et al. @JAMAOnc jamanetwork.com/journals/jamao… #liquidbiopsy #camoldx #lcsm
  • user avatar
    Mike Thompson, MD, PhD, FASCO
    @mtmdphd
    Feb 14, 2021
    Replying to @1pardygirl and @dianaberrent
    No benefit of either. High-Dose Zinc & Ascorbic Acid Supplementation vs Usual Care on Symptom Length & Reduction Among Ambulatory Pts w/ SARS-CoV-2: COVID A to Z RCT [Feb 12, 2021] Thomas et al. @JAMANetworkOpen ow.ly/FIZG50DzeX4
  • user avatar
    Mike Thompson, MD, PhD, FASCO
    @mtmdphd
    Oct 20, 2020
    Interpreting Diagnostic Tests for SARS-CoV-2 [May 6, 2020] @NandiniSethura1 et al. @JAMA_current ow.ly/9GQU30qDLpq #CCC19 #2019nCoV #COVID19 #Testing
  • user avatar
    Mike Thompson, MD, PhD, FASCO
    @mtmdphd
    Jun 11, 2021
    Comprehensive Review of AL amyloidosis: some practical recommendations [May 18, 2021] @rjalhamed et al. @Mohty_EBMT #BCJ ow.ly/U4x650F8awG #OpenAccess #amyloidosis HT @VincentRK
  • user avatar
    Mike Thompson, MD, PhD, FASCO
    @mtmdphd
    Dec 2, 2018
    #ASH18 #mmsm "Top 5" Myeloma Abstract Picks [updated] #ASH18top10 #ASH18VR #ASH18RF #ASH18MT @DrOlaLandgren @End_myeloma @Rfonsi1 @VincentRK @szusmani @Phari